Table 3.
Univariate analysis for survival.
| Parameter | Median OS | p-Value |
|---|---|---|
| Whole series | 13 months | NA |
| Age | <0.0001 | |
| ≥65 years | 15.5 months | |
| <65 years | 10 months | |
| Sex | 0.0323 | |
| Male | 12 months | |
| Female | 15 months | |
| KPS | <0.0001 | |
| ≥70 | 15.5 months | |
| <70 | 7.5 months | |
| EOR | <0.0001 | |
| GTR | 14.5 months | |
| STR | 10 months | |
| biopsy | 4.5 months | |
| EGFRvIII | 0.6559 | |
| positive | 13 months | |
| negative | 13 months | |
| MGMT promoter | 0.0555 | |
| methylated | 13 months | |
| unmethylated | 12.5 months | |
| Proliferative index | 0.2804 | |
| ≥30% | 13 months | |
| <30% | 13 months | |
| VEGF | 0.8747 | |
| hyperexpressed | 13 months | |
| not hyperexpressed | 11 months |
EOR, extent of resection; KPS, Karnofsky performance status.